Polymorphism of IL‐12/IL‐23 axis is associated with coronary heart disease

Jiangtao Dong,Qianwen Chen,Tian Xie,Mengru Wang,Mengqi Wang,Lingfeng Zha
DOI: https://doi.org/10.1111/jcmm.18100
2024-01-10
Journal of Cellular and Molecular Medicine
Abstract:IL12B encodes the shared p40 subunit (IL‐12p40) of IL‐12 and IL‐23, which have diverse immune functions and are closely related to the occurrence and development of atherosclerosis (AS). However, the exact role of IL12B in coronary heart disease (CHD) was still unknown. A case–control association analysis was performed between five single nucleotide polymorphisms (SNPs) of IL12B (rs1003199, rs3212219, rs2569254, rs2853694 and rs3212227) and CHD in Chinese Han population (1824 patients with CHD vs. 2784 controls). Logistic regression analyses were used to study the relationships between SNPs and CHD, while multiple linear regression analyses were used to test the association between the SNP and the severity of CHD. In addition, the plasma IL12B concentration of CHD patients were detected by ELISA. We detected a significant association between one of the SNPs, rs2853694−G and CHD (padj = 2.075 × 10−5, OR, 0.773 [95% CI, 0.686–0.870]). Stratified analysis showed that rs2853694 was associated with CHD in both male and female populations and was significantly associated with both early‐ and late‐onset CHD. In addition, rs2853694 is also related to the different types of CHD including clinical‐CHD and anatomical‐CHD. Moreover, there are significant differences in serum IL12B concentrations between rs2853694−TT carriers and rs2853694−GT carriers in CHD patients (p = 0.010). A common variant of IL12B was found significantly associated with CHD and its subgroups. As a shared subunit of IL‐12 and IL‐23, IL‐12p40 may play a key role in IL‐12/IL‐23 axis mediated AS, which is expected to be an effective therapeutic target for CHD.
cell biology,medicine, research & experimental
What problem does this paper attempt to address?